Recent LGVN News
- Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) • GlobeNewswire Inc. • 10/29/2024 02:00:00 PM
- Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting • GlobeNewswire Inc. • 10/27/2024 07:10:00 PM
- Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) • GlobeNewswire Inc. • 10/14/2024 01:05:00 PM
- Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting • GlobeNewswire Inc. • 10/09/2024 01:05:00 PM
- Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day • GlobeNewswire Inc. • 10/07/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 10:30:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 10:30:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 10:30:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 10:30:10 PM
- Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference • GlobeNewswire Inc. • 10/02/2024 01:05:00 PM
- Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa • GlobeNewswire Inc. • 09/26/2024 01:05:00 PM
- Longeveron® Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B™ in Hypoplastic Left Heart Syndrome (HLHS) • GlobeNewswire Inc. • 09/03/2024 01:00:00 PM
- Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 08/26/2024 08:05:00 PM
- Cisco Beats Estimates and Announces Restructuring, Canoo Rises 6%, Lulus Losses Widen, Latest in Earnings • IH Market News • 08/15/2024 10:08:19 AM
- Longeveron® Announces Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/14/2024 08:05:00 PM
- U.S. Futures Steady After Tuesday’s Strong Recovery; CPI in Focus • IH Market News • 08/14/2024 09:58:49 AM
- Longeveron® to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024 • GlobeNewswire Inc. • 08/05/2024 08:05:00 PM
- Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC) • GlobeNewswire Inc. • 07/28/2024 08:51:00 PM
- Longeveron Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/19/2024 08:05:00 PM
- Longeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/18/2024 12:45:00 PM
- Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B™ for the Treatment of Mild Alzheimer’s Disease • GlobeNewswire Inc. • 07/17/2024 12:00:00 PM
- Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer’s Disease • GlobeNewswire Inc. • 07/10/2024 11:30:00 AM
- Neha Motwani Elected to Longeveron® Board of Directors • GlobeNewswire Inc. • 07/09/2024 01:00:00 PM
- Gene Therapy Pioneer Roger Hajjar, MD, Elected to Longeveron® Board of Directors • GlobeNewswire Inc. • 07/08/2024 01:00:00 PM
- Life Science Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 06/21/2024 12:35:00 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM